Pharmacology, Biochemistry and Behavior 1996: Vol 53 Index

9 Pages·1996·2.4 MB·English

PHARMACOLOGY
BIOCHEMISTRY
ANN.D
BEHAVIOR
VOLUME 53, 1996
SUBJECT AND AUTHOR INDEX
ELSEVIER
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Founded by MATTHEW J. WAYNER
US Editor-in-Chief European Editor-in-Chief
GEORGE F. Koos SANDRA E. FILE
Department of Neuropharmacology, CVN7 Psychopharmacology Research Unit
The Scripps Research Institute Guy’s Hospital Medical School
10666 N. Torrey Pines Road P.O. Box 3448
La Jolla, CA 92037, USA London SE1 9QH, UK
Fax: [phone] Fax: [phone]
E-mail: [email protected] E-mail: [email protected]
Editorial Advisory Board
LIISA AHTEE, Helsinki, Finland J. DAVID LEANDER, Indianapolis, IN
LEMBIT ALLIKMETS, Tartu, Estonia EMINY H. Y. LEE, Taipei, Taiwan
ROBERT L. BALSTER, Richmond, VA ALLEN S. LEVINE, Minneapolis, MN
GIOVANNI BIGGIO, Cagliari, Italy WILLIAM J. McBRIDE, Indianapolis, IN J
MIKE BRILEY, Castres, France DONALD E. McMILLAN, Little Rock, AR j
ALLAN C. COLLINS, Boulder, CO JACK H. MENDELSON, Belmont, MA
DONALD V. COSCINA, Toronto, Ontario, Canada FATHY S. MESSIHA, Grand Forks, ND
JACQUELINE N. CRAWLEY, Bethesda, MD ROBERT D. MYERS, Greenville, NC
ANNETTE DOMENEY, Geneva, Switzerland R. JOHN RODGERS, Leeds, UK
ADRIAN J. DUNN, Shreveport, LA JAQUELINE SAGEN, Chicago, IL
BURR EICHELMAN, Philadelphia, PA ROSARIO SAMANIN, Milan, Italy
WILLIAM J. FREED, Washington, DC HERMAN H. SAMSON, Winston-Salem, NC
MANUEL FREIRE-GARABAL, Santiago De Compostela, Spain PAUL R. SANBERG, Tampa, FL
RICHARD A. GLENNON, Richmond, VA PHIL J. SKOLNICK, Bethesda, MD
F. G. GRAEFF, Sao Paulo, Brazil LINDA P. SPEAR, Binghamton, NY
M. R. C. GREENWOOD, Davis, CA CLARE STANFORD, London, UK
ROLAND R. GRIFFITHS, Baltimore, MD MARIE-HELENE THIEBOT, Paris, France
STEPHEN G. HOLTZMAN, Atlanta, GA DEREK VAN DER KOOY, Toronto, Ontario, Canada
AKIRA HORITA, Seattle, WA JEANNE M. WEHNER, Boulder, CO
CHRIS-ELLYN JOHANSON, Detroit, MI BRUNO E. WILL, Strasbourg, France
HAROLD KALANT, Toronto, Ontario, Canada J.C. WINTER, Buffalo, NY
G. JEAN KANT, Washington, DC ALICE M. YOUNG, Detroit, MI
KATHLEEN M. KANTAK, Boston, MA IAN S. ZAGON, Hershey, PA
CONAN KORNETSKY, Boston, MA
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Managing Editors:
In the US: In Europe:
Gery Schulteis Cathy Fernandez
E-mail: [email protected] E-mail: [email protected]
Production Editor:
John Fotia
E-mail: [email protected]
Publishing and Advertising Office:
Elsevier Science Inc., 660 White Plains Road, Tarrytown, NY 10591-5153, USA
E-mail Address: [email protected]
Subscription Office: 4
Elsevier Science Inc., 655 Avenue of the Americas, New York, NY 10010-5017, USA 4
Published Monthly
Annual Institutional Subscription Rate (1996): US$1825.00. Associated Personal Subscription Rates
are available on request for those whose institutions are library subscribers. Prices include postage
and insurance and are subject to change without notice.
Pharmacology Biochemistry and Behavior is an official journal of the International Behavioral Neuroscience
Society. For information about the society, please contact: Marianne Van Wagner, IBNS Central Office, Division 9
of Life Sciences, The University of Texas at San Antonio, 6900 North Loop 1604 West, San Antonio, TX 78249- 4
0662, USA. E-mail: [email protected]; Fax: (210) 691-4510. Members of the International
Behavioral Neuroscience Society may order personal subscriptions at a concessional rate; details of this rate are a
available upon request.
Pharmacology Biochemistry and Behavior, Vol. 53, No. 4, pp. I-VIII, 1996
Copyright © 1996 Elsevier Science Inc.
Printed in the USA. All rights reserved
0091-3057/96 $15.00 + .00
ELSEVIER
SUBJECT INDEX
Abecarnil, 87, 1005 Associative learning, 649 CCPA, 249
Aberrant drinking, 33 Atropine, 463 Central administration, 665
Absence, 73 Attention, 163, 213, 617 Cerebellum, 147
Acetylcholine, 179, 679, 783, 809 Atypical opioid systems, 433 CGP 35348, 943
ACTH, 517, 641, 965 Audiogenic-like seizures, 503 CGS8216, 87
ACTH analog, 163 Audiogenic seizures, 503 Chicken embryo, 603
Activity, 303, 701 Auto-addiction, 433 Chlordiazepoxide, 593
Addiction, 11, 433, 791, 809 Aversion, 511 Chlorpromazine, 115
Adenosine A, receptors, 341 (A‘’), 425 Choline, 783
Adjunctive behavior, 123 Cholinergic activity, 613
Adrenal weight, 965 Baclofen, 73, 303 Cholinergic antagonist, 463
Aging, 641 Barakol, 753 Cholinergic neurochemistry, 771
Agonists, 995 Behavior, 493, 995 Cholinergic pathways, 735
Agouti, 425 Behavior genetics, 623 Cholinergic stimulation, 1017
Aggression, 329 Benactyzine, 463 Cholinergic system, 713
Aggressive behavior, 951 Benzodiazepine, 1, 87, 593, 1005 Cholinesterase inhibition, 771
Alcohol, 585 Benzodiazepine receptors, 581, 723 Chronic administration, 935
Alcohol aversion, 487 Benzoylecgonine, 133 Chronic ethanol, 249
Alcohol intake, 891 8-Adrenoceptor antagonists, 903 Chronic methamphetamine, 437
Alcohol-nonpreferring rats, 487, 585 8-Adrenoceptors, 1017 Chronic stress, 517
Alcohol-preferring rats, 487, 585 B-Endorphin, 425 Cigarettes, 355
Alcohol reinforcement, 487 B-FNA, 927 Cingulate cortex, 617
Alcohol sensitivity, 585, 723 Bicuculline, 629, 673 Circadian, 843
Alcohol tolerance, 585 Black bear, 885 Circadian rhythm, 141
a-Methyl-p-tyrosine, 379 Blink reflex, 857 Circadian wheel-running activity, 843
aMPT, 1 Body temperature, 657 Citalopram, 825
a,-Adrenoceptors, 1017 Body weight, 657 Classical conditioning, 147
a,-Adrenoceptors, 291, 1017 Brain, 205, 843 Clonidine, 1, 291, 979
Alphaxalone, 777 Brain angiotensin, 687 CO,, 205
Allopregnanolone, 777 Brain cholinergic systems, 687 Cocaethylene, 133
Amino acids, 549 Brain damage, 163 Cocaine, 5, 57, 185, 191, 133, 227, 243,
Amnesia, 391 Brain injury, 679 525, 623, 695, 747, 863, 911, 919
Amphetamine, 511, 695, 741, 817, 833 Brain monoamines, 469 Conditioned fear stress, 825
Anabolic-androgenic steroids, 329 Brain phospholipid, 843 Conditioned place preference, 99, 185, 191,
Analgesia, 133, 567, 665, 927, 943 Brain serotonergic systems, 687 531, 657
Androgen, 741 Branched-chain amino acids, 449 Conditioned taste aversion, 243, 657, 891
Androgen-dependent behavior, 213 Bretazenil, 723 Conditioned taste avoidance, 657
Animal model, 11, 123 Bromocriptine, 833 Conflict behavior, 369
Aniracetam, 277, 943 Burimamide, 567 Conflict responding, 593
Anorexant khat, 297 Continuous drug infusion, 713
Anorexia, 839 Convulsions, 493
Cadmium, 687
Anorexia nervosa, 123, 433: Corticosterone, 641
Cadmium intoxication, 687
Antagonists, 995 Cadmium neurotoxicity, 687 CP 55,940, 657
Antianxiety, 493 CPP, 799
Calcium-calmodulin protein kinase activ-
Anticonvulsant, 87 Crab, 441
ity, 155
Anticonvulsant drugs, 559 Crack, 57
Calorimetry, 549
Antinociception, 205, 411, 449, 567, 943 Cromakalim, 839
Cannabinoid, 657
Antipsychotic, 493 Cue learning, 303
Cannabis, 657
Anxiety, 271, 369, 541, 825, 1005 Cyproheptadine, 441
Carbamazepine, 243, 559
Anxiogenic drugs, 271
Carbon monoxide, 355:
Anxiolysis, 87
Cardiovascular, 927 d-Amphetamine, 297
Anxiolytics, 271, 369, 753, 825
Cardiovascular responses, 927 DA D, receptors, 525
A, receptors, 249
Cassia siamea, 753 DAMPGO, 927
Apomorphine, 335, 417, 817, 833
Catalepsy, 437 Daytime activity, 265
Aprophen, 463
Catecholamines, 141, 213 Defensive reflex, 857
Arecoline, 713
CCK, 493 Dehydroepiandrosterone, 51
Ifl
IV SUBJECT INDEX
d-Fenfluramine, 641 Fear, 649 Hibernation, 885
6-Opioid receptor, 477 Feeding, 1005 Hibernation-induction trigger, 885
6-Receptor, 665 Felbamate, 559 High responder, 191
Dependence, 11, 791 Female, 433 Hippocampus, 361, 613, 899
Depression, 535 Female F-344 rat, 641 Histamine, 347
Development, 41, 425, 603 Fenfluramine, 99, 511 Histamine H,-receptor antagonist, 567
Dexfenfluramine, 549 FG5865 Fimbria lesion, 163 Histamine H,-receptor antagonist, 567
p-Fenfluramine, 155 58-Pregnanediol, 777 Histamine H,-receptor agonist, 567
Diazepam, 115, 271, 317, 753, 1005 5-HIAA, 965 Histamine H,-receptor antagonist, 567
Diestrus-2, 965 5-HT (5-hydroxytryptamine, serotonin), Histaminergic, 347
Dizocilipine, 701 995 H, receptors, 347
D-Norfenfluramine, 155 5-HT receptors, 107 Horizontal activity, 877
DOI, 603 5-HT,, receptor, 385, 825 Hormone, 27
Dominance, 285 5-HT,, receptors, 257 Hot-plate analgesia test, 449
Dominance rank, 11 5-HT p/p, 535 HPNS, 257
D, receptors, 481, 759 5-HT, receptors, 271, 765 H, receptors, 347
DOPAC, 41, 575 5-HT,- receptor, 107, 385 H, receptors, 347
Dopamine, 41, 99, 179, 221, 257, 285, 417, 5-Hydroxytryptamine, 33, 1023 Hyperactivity, 185
455, 493, 575, 641, 695, 863 5,7-DHT, 951 Hyperphagia, 87, 1005
Dopamine agonists, 481, 759 Fixed-ratio schedule, 979 Hypoalgesia, 649
Dopamine antagonists, 481, 759 Flunarizine, 155 Hypothalamic 5-HT, 965
Dopamine (DA), 425 Fluvoxamine, 265 Hypothalamus, 425
Dopamine D, receptors, 935 Food, 995 Hypothermia, 87, 657
Dopamine D,/D, receptors, 935 Food competition, 951
Dopamine neurotransmission, 107 Food intake, 221, 297, 425, 433, 777, 839, Ibogaine, 863
Dopamine receptor supersensitivity, 185 1023 Immunity, 227
Dopamine release, 155 Food-related drinking, 347 Impromidine, 567
Dopaminergic stimulation, 1017 Food restriction, 995
Individual differences, 191, 511
Dothiepin, 265 Food reward, 221 Indole levels and release, 155
DPDPE, 885 Foot-shock, 735 Inferior colliculus lesions, 503
[D-Pen’]-enkephalin, 877 Forced, 843 Inferior colliculus nuclei, 503
[D-Pen’]-enkephalin, 877 Forced swimming, 469
Infusion, 309
Drinking, 347 Forced swimming test, 843 Ingestion, 731
Drinking behavior, 687 Formalin, 411 Ingestive behavior, 657
Drug abuse, 657, 871 Fowls, 995
Insulin, 549
Drug aerosols, 57 Free fatty acids, 549 Intracerebral injection, 541
Drug discrimination, 107, 455, 891, 979 Freezing behavior, 825 Intracranial self-stimulation, 741
Drug reinforcement, 477 Functional recovery, 163 Intrauterine cocaine, 857
Drug reward, 511
Intravenous, 309
Drugs of abuse, 243, 617 GABA, 27, 51, 629, 943, 995
In vitro binding, 41
DSP-4, 213, 391 GABA (y-aminobutyric acid), 995 In vivo microdialysis in freely moving rats,
D, Receptor, 695 GABA,, 971 99
D, dopamine receptors, 291 GABA, receptors, 361 Ipsapirone, 825, 891
D, Receptor, 695, 759 GABA, receptor subtypes, 723 Isolation, 41
Duration, 965 GABAg, 73, 303 Isradipine, 243
Dynorphin A, 885 GABA, receptor, 943 IV, 919
GABA, receptor, 777
Eating disorders, 433 y-Butyrolactone, 73
Juvenile rats, 987
Ecgonine, 133 y-Hydroxybutyric acid, 73
Ecgonine methyl ester, 133 y-Linolenic, 843
EEG, 73 y-Linolenic acid, 843 x-Agonists, 411
8-OH-DPAT, 323, 385 Gastric emptying, 839 x-Opioid, 863
Ejaculation, 329 Gastric lesion, 957 k-Receptor, 665
Electrophysiology, 493 GBR12909, 911 K* channel opener, 839
Elevated plus-maze, 271, 753 Generalization, 891
Elicited PGO waves, 323 Genetics, 425, 585, 871 Lamotrigine, 559
Endogenous opioid peptides, 81 Ginger, 271 Lapping, 853
Endogenous opioids, 613 Ginkgo biloba, 271 Lateral hypothalamus, 417
Energy metabolism, 549 Glucose, 549 Laterodorsal tegmental nucleus, 323
Environment-specific sensitization, 899 Glycine, 791 Learning, 317, 385, 765
Epilepsy, 73 Glycogen, 549 Learning/memory, 735, 943
Essential, 843 Gnawing behavior, 67 Licking, 853
Essential fatty acids, 843 GR 127935, 535 Lithium, 511
Estrogen, 27 Grooming, 935 Locomotion, 335, 935
Ethanol, 11, 51, 891, 919, 971 Guinea pig, 799 Locomotor activity, 87, 191, 257, 481, 535,
Ethanol alcohol preference, 33 Guinea pig ileum, 885 623
Ether stress, 965 Long-term facilitation, 735
Eticlopride, 759 Habituation, 401, 517, 857 Loreclezole, 723
Etonitazene, 11, 871 HAD rats, 33 Loss of control, 11
Evoked potentials, 817 Halcion, 317 Low responder, 191
Exploratory head dipping, 877 Haloperidol, 401, 437, 833, 853 Lymphocyte, 227
Ex vivo binding, 41 Handling for vaginal smear screening, 965 LY 262691, 493
SUBJECT INDEX
Majonoside-R2, 957 Nor-binaltorphimine, 411 Pregnenolone, 51, 777
Male, 433 Norcocaine, 133 Pregnenolone sulfate, 51
Maze, 463 Norepinephrine, 141, 213, 235, 641, 1023 Prenatal, 843
Maze-learning selected chicks, 581 Novelty, 191 Prenatal alcohol effects, 197
Mazindol, 911 NPC 17742, 791 Prenatal cocaine, 617, 857
MBDB, 99 NS-3 (CG3703), 391 Prenatal cocaine effects, 197
mCPP, 107 Nucleus accumbens, 99, 221, 635, 747, 809 Prenatal ethanol intoxication, 361
MDMA, 99, 455, 477 Nucleus basalis, 277 Prepubertal, 987
Medial frontal cortex, 641 Nucleus basalis magnocellularis (NBM), Pressure, 257
Medial prefrontal cortex, 5 391 Problem solving, 197
Memantine, 791 Progestin, 27
Membrane, 27 Obesity, 425, 549 Progressive ratio, 5, 115
Memory, 51, 317, 361, 385 Object recognition, 277 Prolactin, 379, 641
Memory and learning, 713 Obsessive-compulsive disorder, 123 Propranolol, 979
Menthol, 355 Ontogeny, 575 pseudo-Parkinsonism, 853
Metergoline, 1023 OPC-14597, 903 Psychological stress, 957
Methamphetamine, 575 Open field, 303 Psychomotor performance, 265
Methiothepin, 155 Open-field test, 833 Purposeless chewing, 179
Methylecgonidine, 57 Operant response, 335 Pyruvate kinase, 549
Methylnaloxonium, 809 Operant test battery, 115
Mice, 285, 329, 411, 425, 433, 437, 701, Opiate antagonists, 81, 987 Quinpirole, 379, 759
735, 843 Opiates, 11, 81, 809, 871
Microdialysis, 221, 575, 679, 747, 809 Opioids, 67, 433, 871, 885, 987 Rabbit, 857
Microwaves, 613 Oral, 919, 995 (R)-a-methylhistamine, 567
Midazolam, 649 Oral movements, 935 Race, 355
(—) Eticlopride, 525 Organophosphate, 771 Rat pup, 41
(—)-Norpseudoephedrine, 297 ORG2766, 163 Rats, 1, 11, 73, 205, 249, 271, 291, 335,
(—)-3-PPP, 903 Osmotic minipumps, 713 341, 379, 385, 391, 433, 455, 463, 531,
MK-801, 369, 701 559, 593, 657, 679, 765, 809, 853, 871,
MMAI, 99 Pain, 411, 449, 567 891, 919, 971, 979, 1013
Moclobemide, 469 Palatability, 221, 731 Rearing, 877
Morphine, 227, 411, 433, 511, 531, 731, Panax ginseng, 185 Receptor, 995
791, 809, 979, 1013 Paradoxical sleep, 291 Reference memory, 463
Morphine derivatives, 665 Paraventricular nucleus, 1023 Reflex modification, 857
Morris maze, 163 Parental behavior, 987 Reinforcement, 5, 243, 657, 971
Morris water maze, 303, 783 Parkinsonian bradykinesia, 335 Repeated prenatal exposure, 771
Motility, 525 Parkinsonism, 179 Repeated testing procedures, 369
Motivation, 115 Partial agonists, 87 Resistance, 965
Motor, 179 Particle-size aerosol, 57 Response decrements, 853
Mouse, 673, 877 Passive avoidance, 735 Response sequence, 335
Mouse spleen, 141 Passive avoidance response, 391 Restraint, 205, 927
MSG, 425 Pavlovian conditioning, 617 Retrograde messenger, 147
Mu-opioid, 927 Peak force, 853 Reward, 99, 191, 417, 657, 695, 731
u-Receptor, 665 Peak procedure, 759 Ritanserin, 603
Muscimol, 629, 971 Pedunculopontine tegmental nucleus, 323 RO 41-9067, 291
Penile erection, 525 Ro16-6028, 87
Naloxone, 81, 411, 885 Pentobarbital-induced sleep, 957 Ro23-1590, 87
Naltrexone, 987 Pentylenetetrazole, 73, 673 Ro23-0364, 87
Naltrindole, 477 Performance, 317 Rotation, 903
Neonatal exposure, 197 Peripheral chemoreceptors, 341 RTI-55, 911
Neuroactive steroid, 27 Petit mal, 73 RU 24969, 535
Neuroactive steroids, 777 PGO waves, 323 Running wheel activity, 329
Neurosteroids, 27, 51 Phaclofen, 73
Nicotinamide, 783 Phenobarbital, 369, 559 Saccharin, 919
Nicotine, 81, 309, 355 PI turnover, 107 Saccharin taste aversion, 695
Nicotine abstinence, 81 Picrotoxin, 673 Saclofen, 73
Nicotine dependence, 81 Piracetam, 943 Salbutamol, 979
Nicotine withdrawal, 81, 635 Place aversion, 99 Schizophrenia, 493
Nictitating membrane, 617, 857 Place conditioning, 487, 511 SCH23390, 437, 759
Nitric oxide, 147, 673, 1013 Place preference, 511, 1013 Scopolamine, 277, 463, 679, 713, 735, 853
NMDA antagonists, 799 Plaque-forming cell response, 235 Seizure, 73
NMDA receptor antagonists, 701, 791 Plasma, 927 Selected rat lines, 723
NMDA receptors, 799 Plasticity, 147 Selective breeding, 871
N-Methyl-DL-aspartate, 673 (+ )-Amphetamine, 455 Self-administration, 5, 919, 971
N‘-p-Sulfophenyladenosine (p-SPA), 341 (+ )-Fenfluramine, 455 Self-stimulation, 417
Nociception, 27, 133 (+)MK-801, 799 Sensitization, 441, 585, 623, 911, 935
Nw-Nitro-L-arginine, 673 (+ )Cyanopindolol, 257 Sensorimotor, 701
Nongenomic, 27 Plus-maze, 1005 Sensorimotor integration, 857
Nootropic, 943 Polydrug exposure, 197 Sensory gating, 817
Noradrenaline, 285, 541 Postictal prolactin, 503 Septal area, 541
Noradrenergic, 979 Prazosin, 979 Serotonin, 123, 257, 271, 323, 455, 441,
Noradrenergic activity, 517 Prefrontal cortex, 809 549, 641, 765, 747, 825, 863, 891
Vi SUBJECT INDEX
Serotonin agonists, 385 Striatum, 179, 257, 575, 635 U-50488H, 411
Serotoninergic activity, 517 Strong learning, 629 U78875, 87
Serotonin (5-HT), 425 Subdiaphragmatic vagotomy, 839 Uncontrollable foot-shock, 877
Serotonin receptors, 33 Substantia nigra, 493 Undernourished pigeon, 951
Serotonin reuptake inhibitor, 123 Substantia nigra lesions, 503
Serotonin, receptors, 603 Sucrose, 731, 971 Vacuous chewing, 179
7-Hydroxy-N, N-di-n-propyl-2- Sweet solution consumption, 243 Vacuous chewing movements, 401
aminotetralin, 695 Valium, 317
7-OH-DPAT, 379, 695 Tail-flick latency, 27 Vapor pressure, 57
178-Estradiol, 379 Tail-flick test, 665 Ventral tegmental area (VTA), 971
Sex, 433 Taste, 731 Ventral tegmentum, 493
Sexual behavior, 329, 525 Taste aversion, 511, 839 Viable yellow, 425
Sigma receptor, 695 Taste avoidance, 511 Vietnamese ginseng extract, 957
6-Hydroxydopamine, 5, 817 Taste reactivity, 731 Vietnamese ginseng total saponin, 957
SKF 38393, 759 Temporal response differentiation, 115 Vocal control system, 213
Sleep, | TFMPP Voltammetry, 257
Sleep apneas, 341 Thigmotaxia, 303
Sleep-wake cycle, 559 Time course, 369, 935 Water intake, 297
Smoking, 309 Time estimation, 115, 759 Water maze, 317, 385
Social behavior, 11 Tolerance, 227, 593 Weak learning, 629
Social isolation, 11, 531 Tongue, 853 Withdrawal, 249, 593, 791, 809
Spatial learning, 303, 361 Tongue protrusions, 935 Women, 355
Spatial learning and memory, 701 Topography, 355 Working memory, 277, 463
Spatial working memory, 541 Tremor, 179
SRBC, 235 Triazolam, 317 Yawning, 903, 1017
Stereotyped behavior, 525 Trifluperazine, 155 Yohimbine, 979
Stereotypy, 903, 935 Trihexyphenidyl, 463
Steroid mechanism, 27 Tropane, 133 ZG-63, 723
Stimulants, 481 Turnover, 41 Zolpidem, 723
Stone maze, 713 (2-[4-[4,4-bis(4-fluoropheny]l)butyl]-1-
Stress, 41, 123, 205, 235, 641, 735 piperazinyl]-3-pyridinecarboxamide), 33
Stress model, 469 Type A monoamine oxidase inhibitor, 469
Stress susceptibility, 581
VOLUME 53 1996
AUTHOR INDEX
Abraini, J. H., 257 Bruce, D. S., 885 Doretto, M. C., 503 Gobbi, M., 155
Adami, M., 559 Bulcdo, C., 687 Drummond, L., 235 Goldberg, S. R., 623, 911
Aggio, J., 441 Butterfield, D. A., 665 Duc, N. M., 957 Gong, W., 191
Ahijevych, K., 355 Duncan, J. E., 27 Gordon, B. H., 641
Akiyama, K., 575 Caccia, S., 155 Dykstra, L. A., 979 Gorelick, D. A., 623, 911
Ali, S. F., 425 Campbell, D. B., 641 Graefe, J. F., 57
Allen, J. D., 759 Campmany, L., 517 Egan, M. F., 401 Grauer, E., 463
Allen, M. T., 147 Caputo, F. A., 425 Ellison, T., 481 Grota, L. J., 141
Altemus, M., 123 Carino, M. A., 613 Elmer, G. I., 623, 911 Grouhel, A., 411
Amendola, C. A., 477 Carley, D. W., 341 Endo, T., 673 Guy, A. W., 613
Anderson, T. M., 635 Carlson, K. R., 871
Anelli, M., 155 Carrol, F. 1., 911 Fachinelli, C., 951 Habash, T., 979
Anisman, H., 235 Carroll, M. E., 919 Fairweather, D. B., 265 Hacker, R., 271
Antunes-Rodrigues, J., 503 Carter, V. A., 81 Fang, C. P., 57 Hall, F. S., 417
Arce, A., 581 Casamenti, F., 277 Fantino, M., 221 Hammond, J., 843
Armario, A., 517 Chanda, S. M., 771 Felten, D. L., 141 Handa, R. J., 641
Arolfo, M. P., 361 Chappelle, A. M., 972 Felten, S. Y., 141 Hansen-Trench, L., 197
Ashford, J., 265 Chen, H. A., 87 Ferguson, J., 401 Hara, S., 673
Askanazi, J., 449 Chen, S.-W., 87, 777 Ferguson, S. A., 115 Haraguchi, M., 972
Cho, D.-H., 185 Fernandez, A. G., 535 Harding, C. F., 213
Badiani, A., 899 Cinquanta, M., 155 Ferrari, F., 525 Harvey, J. A., 617, 857
Bailey, E. C., 885 Clark, A. S., 741 Ferreira, H., 687 Hasenohrl, R. U., 271
Baker, G., 5 Clash, K., 41 Ferri, N., 559 Hashim, A., 863
Baker, L. E., 455 Clelford, J., 235 Fink, H., 1005 Hayes, R. L., 679
Balcaen, P., 843 Clements, M. P., 629 Finkell, J., 347 Hellgren, E. C., 885
Bao, J., 679 Commissaris, R. L., 369 Fishkin, M. D., 477 Helton, D. R., 493
Baptista, T., 747 Concas, A., 249 Floris, S., 249 Hernandez, L., 747
Barclay, S. R., 213 Conceicao, I. M., 833 Fowler, S. C., 853 Hernandez, M. C., 227
Bardo, M. T., 695 Cook, D. F., 243 Fraioli, S., 297 Heyne, A., 11
Barnes, C., 433 Coscina, D. V., 1023 Frederick, D. L., 759 Hindmarch, I., 265
Barron, S., 197 Costall, B., 713 Fregoneze, J. B., 687 Hodge, C. W., 971
Bartolini, A., 567, 943 Crespi, D., 155 Frenz, U., 549 Hoebel, B. G., 747, 809
Bartolini, L., 277 Crooks, P. A., 665 Frisch, Ch., 271 Hong, E., 765
Baskin, P., 179 Cuccheddu, T., 249 Frittoli, E., 155 Horita, A., 613
Battles, A. H., 205 Cunha, M., 687 Froehlich, J. C., 585 Horton, N. D., 885
Bayer, B. M., 227 Cunningham, S. J., 81 Frussa-Filho, R., 833 Houdi, A. A., 665, 927
Behm, F. M., 309 Currie, P. J., 1023 Frye, C. A., 27 Hough, L. B., 205
Belotti, M., 541 Czachura, J. F., 493 Fujikawa, M., 903 Huang, Y.-S., 843
Bennett, G. W., 753 Fulginiti, S., 361 Hubbell, C. L., 477
Berger, J. E., 493 D’Amico-Rasmussen, Q., 433 Fung, Y. K., 635 Hughes, C. E., 979
Berra, B., 603 Darlington, C. L., 799 Furukawa, T., 379, 903, 1017 Huong, N. T. T., 957
Bertorelli, R., 559 Das, S., 853 Huston, J. P., 271
Bevins, R. A., 695 Davenport, K. E., 927 Gahtan, E., 919 Hyde, T. M., 401
Biggio, G., 249 Davies, M. F., 87, 777 Gaillard, J. M., 1, 291
Bjork, A., 33 Deachapunya, C., 753 Galanopoulou, P., 965 Inoue, T., 379, 825, 903
Boschmann, M., 549 De Beun, R., 891 Galeotti, N., 943 Ison, M., 951
Bourne, R. C., 629 DE Castro E Silva, E., 687 Galey, D., 541 Issakidis, C. N., 657
Bourson, A., 107 DE Oliveira, I., 687 Galliven, E., 123 Itoh, Y., 391
Boyd, E. A., 753 DE Saint Hilaire, Z., 1, 291 Garcia-Cairasco, N., 503 Iwata, N., 673
Bratt, A. M., 713 De Souza Silva, M. A., 271 George, M., 641
Braun, C. J., 347 DE Vry, J., 891 Ghelardini, C., 567, 943 Jacobson, D., 885
Brener, J. M., 335 DEL Prete, E., 839 Ghosh, S., 317 Jagadeesh, J., 355
Bridges, R. S., 987 Delzer, T. A., 695 Gibbons, C. H., 741 Jang, C.-G., 185
Brioni, J. D., 361 Demirci, M., 355 Gillespie, J., 355 Jerram, A. H., 799
Brockington, A., 911 Ding, X. Z., 227 Giorcelli, P., 155 Jodar, L., 735
Bronson, F. H., 329 Dixon, C. E., 679 Gispen, H. W., 163 Johnson, R.«G., 817
Brosnan-Watters, G., 701 Domae, M., 379 Giuliani, D., 525 Johnston, R. E., 649
Browman, K. E., 899 Domeney, A. M., 713 Glowa, J. R., 123 Josephy, M., 163
Vil
Vill AUTHOR INDEX
J. Sleight, A., 107 Maldonado, H., 441 Payne, M. C., 81 Shumsky, J. S., 593
Justice, JR, J. B., 191 Malin, D. H., 81 Pepeu, G., 277 Siegel, S., 511
Malmberg-Aiello, P., 567 Perra, C., 249 Skelton, R. W., 303
Kaiser, D. H., 197 Mann, P. E., 987 Perrella, D., 297 Skipsey, K., 41 -
Kallman, M. J., 493 Manner, T., 449 Petit, N., 107 Skolnick, P., 791
Kalmus, G. W., 33 Marin, R. H., 581 Picker, M. J., 979 Smith, P. F., 799
Kaneto, H., 735 Mark, G. P., 809 Pizzi, W. J., 243 Sparber, S. B., 603
Kang, S.-Y., 185 Markovska, V. L., 369 Pol, O., 517 Sprague, J. E., 99
Kano, S., 673 Marona-Lewicka, D., 99 Pollock, J., 67 Spruijt, M. B., 163
Kant, G. J., 317, 385 Marrazzi, M. A., 433 Pongsakorn, S., 753 Steinmetz, J. E., 147
Kapon, J., 463 Marsden, A. C., 753 Pope, C. N., 771 Stellar, J. R., 417
Katz, D. P., 449 Marsden, C. A., 531 Popik, P., 791 Stephens, D. N., 1005
Keefe, M. E., 347 Marson, L., 927 Powers, R. H., 133 Stevens, K. E., 817
Kehoe, P., 41 Martel, B., 221 Prior, G., 657 Stewart, R. B., 487, 585
Kelley, S. P., 141 Mascia, M. P., 249 Python, A., 291 Strecker, R. E., 335
Kelly, M. E., 713 Matecka, D., 723, 911
Kerr, L., 235 Matsumoto, K., 957 Rada, P. V., 809 Takahashi, M., 735
Kim, H.-S., 185 Mattern, C. M., 271 Radulovacki, M., 341 Tamura, M., 391
Kim, Y.-M., 347 Mattingly, B. A., 481 Rakitin, A., 441 Taylor, K. M., 809
Kimura, H., 1017 Maughan, K. R., 385 Ramalho, M. J., 503 Tejani-Butt, S. M., 323
Teneud, L. M., 747
Kimura, K., 391 Meininger, G. R., 385 Rase, K., 481
Kivastik, T., 1013 Melchior, C. L., 51 Rasmussen, K., 493 Terry, L. C., 133
Klein, J., 783 Mendella, P. D., 877 Reid, L. D., 477 Thongsaard, W., 753
Konstandi, M., 965 Meneses, A., 765 Rex, A., 1005 Toropainen, M., 723
Koppen, A., 783 Mennini, T., 155 Rhee, G.-S., 99 Tramell, M. S., 885
Kornetsky, C., 67 Miles, C., 511 Rheu, H.-M., 185 Tribuzio, R. A., 347
Korpi, E. R., 723 Minetti, A., 361 Rice, J., 133 Trivedi, A., 987
Kostal, L., 995 Mischler, S. A., 205 Rice, K. C., 911 Tsai, J., 477
Kottayil, S., 665 Miura, H., 469 Rideout, H. J., 731 Tsakayannis, D., 965
Koyama, T., 825 Mizuki, Y., 437 Ritzmann, R. F., 51 Tsuchida, K., 575
Kraly, F. S., 347 Monti, D., 341 Rizzo, A., 603 Tsuchiya, K., 825
Kriem, B., 257 Moolten, M. S., 871 Roberts, D. C. S., 5 Turenne, S. D., 511
Kurashima, M., 379 Morrison, A. R., 323 Robinson, T. E., 899
Ujike, H., 575
Kuriiwa, F., 673 Mostallino, M. C., 249 Robinson, III, T. N., 385
Ukai, Y., 391
Kuroda, S., 575 Mukai, T., 673 Rodriguez Echandia, E. L.,
Ushijima, I., 437
Kurtz, D. L., 585 Murphy, C. M., 549 951
Murphy, D. L., 123 Rodriguez, L., 777 VAN DER Staay, F.-J., 783
Labounty, L. P., 919 Murphy, J. M., 487 Romano, A. G., 617, 857 Van Doremalen, E., 163
Lai, H., 613 Murzi, E., 747 Rose, G. M., 817 VAN Loon, G. R., 927
Lajtha, A., 863 Mutsaers, L., 843 Rose, J. E., 309 Van Rijzingen, I. M. S., 163
Lake, R. J., 81 Myers, R. D., 33 Ross, R. J., 323 Vasilakis, A. A., 317
Lamberti, C., 567 Rostain, J.-C., 257 Virgolini, M. B., 361
Lau, Y.-S., 635 Nagashima, M., 379, 903, 1017 Rothman, R. B., 623, 911
Lawhorn, J., 433 Nagatsu, T., 469 Rowlett, J. K., 481 Wainwright, P. E., 843
Leong, Y., 123 Nakahara, D., 469 Rudler, A., 107 Wanner, D., 107
Lévesque, S., 843 Naoi, M., 469 Rutkauskaite, J., 1013 Watanabe, H., 957
Li, T.-K., 487, 585 Nardi, A., 701 Waterman, S. A., 213
Li, X., 575 Naumenko, E. V., 285 Sakai, K., 575 Westman, E. C., 309
Lindenfeld, R. C., 741 Naylor, R. J., 713 Salamone, J. D., 179 Wettstein, J. G., 411
Lindqvist, E., 817 Neely, T. M., 385 Samson, H. H., 972 Wilson, O. B., 81
Liu, X., 335 Neill, D. B., 191 Sanford, L. D., 323 Wolff, G. L., 425
Loew, G. H., 87, 777 Neisewander, J. I., 935 Sarmento, C., 687 Wong, G., 723
Loffelholz, K., 783 Nencini, P., 297 Sarviharju, M., 723 Wongwitdecha, N., 531
Lohmann, A., 891 Nham, N. T., 957 Satta, S., 249 Wood, R. W., 57
Long, D. A., 679 Nichau, Ch., 271 Saulnier-Dyer, C. M., 871 Wozniak, D. F., 701
Long, T. A., 33 Nichols, D. E., 99 Savory, C. J., 995 Wright, W. L., 385
Lorens, S. A., 641 Ninichuk, P. J., 369 Scallet, A. C., 425 Wyler, R., 107
Lucki, I., 593, 935 Noack, R., 549 Scharrer, E., 839 Wylie, R. M., 317
Lumeng, L., 487 Nonaka, K. O., 503 Schmid, M. J., 635 Wyvell, C., 919
Luthman, J., 817 Schmidt, B. H., 783
Xie, Z., 369
Lutz, T. A., 839 Oeltgen, P. R., 885 Schneider, R., 891
Ogasawara, T., 391 Schuelke, G. S., 133 Yamada, K., 379, 903, 1017
McBride, W. J., 487 Oh, K.-W., 185 Segar, T. M., 197 Yamada, M., 437
McCutcheon, D., 843 Ohta, T., 469 Seong, Y.-H., 185 Yamasaki, K., 957
McGonigle, P., 935 Okimoto, L., 987 Serova, L. I., 285
Yoshikuni, Y., 391
McGregor, A., 5 Olney, J. W., 701 Sershen, H., 863
McGregor, I. S., 657 O’Neill, M. F., 535 Setran, D. P., 885 Zacharko, R. M., 877
McNamara, R. K., 303 Ongini, E., 559 Sfikakis, A., 965 Zaharia, M., 235
McQuarters, A., 433 Shirakawa, K., 379 Zaias, J., 987
Madden, J. A., 133 Palacios, J. M., 535 Shoemaker, W. J., 41 Zharkovsky, A., 1013
Madden, K. S., 141 Parker, L. A., 511, 731 Shojaie, J., 57 Zweifel, M., 585
Makhay, M. M., 455 Paule, M. G., 115 Short, P. E., 81 Zwingelstein, C., 107